Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18404672rdf:typepubmed:Citationlld:pubmed
pubmed-article:18404672lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:18404672lifeskim:mentionsumls-concept:C0007634lld:lifeskim
pubmed-article:18404672lifeskim:mentionsumls-concept:C0029463lld:lifeskim
pubmed-article:18404672lifeskim:mentionsumls-concept:C1326912lld:lifeskim
pubmed-article:18404672lifeskim:mentionsumls-concept:C0032824lld:lifeskim
pubmed-article:18404672lifeskim:mentionsumls-concept:C0033414lld:lifeskim
pubmed-article:18404672pubmed:issue2lld:pubmed
pubmed-article:18404672pubmed:dateCreated2008-6-2lld:pubmed
pubmed-article:18404672pubmed:abstractTextPotassium channels, the most diverse superfamily of ion channels, have recently emerged as regulators of carcinogenesis, thus introducing possible new therapeutic strategies in the fight against cancer. In particular, the large conductance Ca(2+)-activated K(+) channels, often referred to as BK channels, are at the crossroads of several tumor-associated processes such as cell proliferation, survival, secretion and migration. Despite the high BK channel expression in osteosarcoma (OS), their function has not yet been investigated in this malignant bone pathology. Here, using stable RNA interference to reduce the expression of hSlo, the human pore-forming alpha-subunit of the BK channel, in human Cal72 OS cells, we show that BK channels play a functional role in carcinogenesis. Our results reveal for the first time that BK channels exhibit antitumoral properties in OS in vivo and affect the tumor microenvironment through the modulation of both chemokine expression and leukocyte infiltration.lld:pubmed
pubmed-article:18404672pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18404672pubmed:languageenglld:pubmed
pubmed-article:18404672pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18404672pubmed:citationSubsetIMlld:pubmed
pubmed-article:18404672pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18404672pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18404672pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18404672pubmed:statusMEDLINElld:pubmed
pubmed-article:18404672pubmed:monthJullld:pubmed
pubmed-article:18404672pubmed:issn1097-0215lld:pubmed
pubmed-article:18404672pubmed:authorpubmed-author:DuboisJean-Ma...lld:pubmed
pubmed-article:18404672pubmed:authorpubmed-author:Schmid-Allian...lld:pubmed
pubmed-article:18404672pubmed:authorpubmed-author:Rouzaire-Dubo...lld:pubmed
pubmed-article:18404672pubmed:authorpubmed-author:RezzonicoRoge...lld:pubmed
pubmed-article:18404672pubmed:authorpubmed-author:Schmid-Antoma...lld:pubmed
pubmed-article:18404672pubmed:authorpubmed-author:BarthelRobert...lld:pubmed
pubmed-article:18404672pubmed:authorpubmed-author:MograbiBahari...lld:pubmed
pubmed-article:18404672pubmed:authorpubmed-author:KarimdjeeBabo...lld:pubmed
pubmed-article:18404672pubmed:authorpubmed-author:VitaleSébasti...lld:pubmed
pubmed-article:18404672pubmed:authorpubmed-author:SoilihiBabou...lld:pubmed
pubmed-article:18404672pubmed:authorpubmed-author:CambienBéatri...lld:pubmed
pubmed-article:18404672pubmed:copyrightInfo(c) 2008 Wiley-Liss, Inc.lld:pubmed
pubmed-article:18404672pubmed:issnTypeElectroniclld:pubmed
pubmed-article:18404672pubmed:day15lld:pubmed
pubmed-article:18404672pubmed:volume123lld:pubmed
pubmed-article:18404672pubmed:ownerNLMlld:pubmed
pubmed-article:18404672pubmed:authorsCompleteYlld:pubmed
pubmed-article:18404672pubmed:pagination365-71lld:pubmed
pubmed-article:18404672pubmed:dateRevised2008-8-22lld:pubmed
pubmed-article:18404672pubmed:meshHeadingpubmed-meshheading:18404672...lld:pubmed
pubmed-article:18404672pubmed:meshHeadingpubmed-meshheading:18404672...lld:pubmed
pubmed-article:18404672pubmed:meshHeadingpubmed-meshheading:18404672...lld:pubmed
pubmed-article:18404672pubmed:meshHeadingpubmed-meshheading:18404672...lld:pubmed
pubmed-article:18404672pubmed:meshHeadingpubmed-meshheading:18404672...lld:pubmed
pubmed-article:18404672pubmed:meshHeadingpubmed-meshheading:18404672...lld:pubmed
pubmed-article:18404672pubmed:meshHeadingpubmed-meshheading:18404672...lld:pubmed
pubmed-article:18404672pubmed:meshHeadingpubmed-meshheading:18404672...lld:pubmed
pubmed-article:18404672pubmed:meshHeadingpubmed-meshheading:18404672...lld:pubmed
pubmed-article:18404672pubmed:meshHeadingpubmed-meshheading:18404672...lld:pubmed
pubmed-article:18404672pubmed:meshHeadingpubmed-meshheading:18404672...lld:pubmed
pubmed-article:18404672pubmed:meshHeadingpubmed-meshheading:18404672...lld:pubmed
pubmed-article:18404672pubmed:meshHeadingpubmed-meshheading:18404672...lld:pubmed
pubmed-article:18404672pubmed:year2008lld:pubmed
pubmed-article:18404672pubmed:articleTitleSilencing of hSlo potassium channels in human osteosarcoma cells promotes tumorigenesis.lld:pubmed
pubmed-article:18404672pubmed:affiliationUniversité de Nice Sophia Antipolis, UFR Sciences, Nice F-06002, France.lld:pubmed
pubmed-article:18404672pubmed:publicationTypeJournal Articlelld:pubmed
entrez-gene:3778entrezgene:pubmedpubmed-article:18404672lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:18404672lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18404672lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18404672lld:pubmed